Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management

Stock Information for Vivani Medical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Vivani Medical Inc.

Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results
Vivani Medical, Inc. Announces Closing of Common Stock Offering
Vivani Medical, Inc. Announces Pricing of Common Stock Offering
Vivani Medical to Present at the ThinkEquity Conference on October 30, 2025
Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off
Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025
Presenting on Emerging Growth Conference 86 Day 2 September 25; Register to live stream
Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.